A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
Premier and 12 national associations voiced support for the Preventing Drug Shortages Act. As the U.S. takes steps in response to the outbreak of the coronavirus, concerns with the integrity of the drug supply chain and the potential impact on downstream drug shortages have surfaced. The Preventing Drug Shortages Act builds upon the prior work of Congress to provide additional authority to the FDA to help mitigate drug shortages and develop market-based incentives to help ensure a stable supply of medications critical for patient care. In the letter, the organizations applaud Reps. Scott Peters (D-CA), Elliot Engel (D-NY), Anna Eshoo (D-CA), Kurt Schrader (D-OR), Brett Guthrie (R-KY), Richard Hudson (R-NC), Michael McCaul (R-TX) and Gus Bilirakis (R-FL) for introducing the bill and for their bipartisan commitment to addressing drug shortages and decreasing healthcare costs while improving patient outcomes.
Contact: Public_Relations@premierinc.com